期刊文献+

顶空气相色谱法测定托拉塞米中6种有机溶剂残留量 被引量:9

Determination of six residual organic solvents in torasemide by headspace capillary gas chromatography
下载PDF
导出
摘要 目的:建立托拉塞米中6种有机溶剂残留量的测定方法。方法:采用顶空毛细管气相色谱法,以二甲基亚砜为溶剂,DB-1毛细管柱(10m×0.53mm×1.5μm),FID检测器。结果:6种残留有机溶剂甲醇、乙醇、异丙醇、二氯甲烷、苯、甲苯均达到了完全分离。结论:该方法灵敏度、准确度均达到有机溶剂残留量的检测要求,可用于托拉塞米中6种残留溶剂的同时检测。 Objective:To develop a headspace capillary gas chromatography for determining the residual organic solvents methanol, ethanol, isopropanol, dichlormethane, benzene and toluene in torasemide. Methods: The samples were dissolved in dimethyl sulfoxide. The six organic solvents were separated on a DB - 1 capillary column ( 10 m×0.53mm×1.5μm) using programmable increased temperature, The intial temperature was kept at 30 ℃ for 3 rain. The temperature was raised to 90 ℃ at the rate of 5 ℃ ·min^-1. Results:Six residual organic solvents consisting of methanol, ethanol, isopropanol, dichlormethane, benzene and toluene in Torasemide were completely separated ,and the samples coincided with the requirements. Condusion:The methods was proved to be accurate and sensitive after validation. It is suitable to the determination of residual organic solvents in Torasemide.
出处 《药物分析杂志》 CAS CSCD 北大核心 2007年第4期569-571,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 顶空气相色谱法 残留有机溶剂 托拉塞米 headspace capillary gas chromatography residual organic solvents Torasemide
  • 相关文献

参考文献6

二级参考文献43

  • 1陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.487.
  • 2[1][1] Blose JS,Adams KF Jr,Patterson JH. Torsemide:a pyridine-sulfonylurea loop diuretic[J]. Ann Pharmacother, 1995,29(4): 396 - 402.
  • 3[2]Brater DC. Clinical pharmacology of loop diuretics [J]. Drugs,1991,41 (Suppl 3) :S14 - S22.
  • 4[3]Frieder HA,Buckley MM-T. Torasemide-a review of its pharmacology, properties and therapeutic potential [J]. Drugs, 1991,41(1) :S81 - S103.
  • 5[4]Bart WH,Smith HL,Karnes HT,et al.Torasemide dose proportionality of pharmacokinetics and pharmacodynamics [J]. Prog Pharmacol Clin Pharmacol, 1990,8: 29 - 37.
  • 6[5]Fowler SF, Murray KM. Torsemide: A new loop diruetic [J].Am J Health-Syst Pharm, 1995,52(15): 1771 - 1780.
  • 7[6]Knauf H,Spahn H,Mutschler E. The loop diuretic torasemide in chronic renal failure: pharmacokinetics and pharmacodynamics [J]. Drugs, 1991,41 (Suppl 3) :S23 - S34.
  • 8[7]Kido H,Ohtaki Y. Torasemide (LUPRAC) :a review of its pharmacological and clinical profile[J]. Nippon Yakeurigaku Zasshi,2001,118(2):97- 105.
  • 9[8]Kruck F. Acute and long term effects of loop diuretics in heart failure[J]. Drugs, 1991,41 (Suppl 3): S60 - S68.
  • 10[9]Barr WH,Smith HL,Karnes HT,et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers[J]. Prog Pharmacol Clin Pharmmol, 1990 ;8:15 - 28.

共引文献74

同被引文献49

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部